Table 1 Classification and clinical rheumatological data of 26 JIA patients
Normal TMJ* group n = 11 | Abnormal TMJ group n = 15 | p-values | |||
|---|---|---|---|---|---|
ILAR diagnosis** | |||||
Oligoarthritis | 3 | (27%) | 4 | (27%) | |
Extended oligoarthritis | 4 | (27%) | |||
Polyarthritis, rheumatoid factor positive | 2 | (18%) | 3 | (20%) | |
Polyarthritis, rheumatoid factor negative | 1 | (7%) | |||
Systemic arthritis | 3 | (27%) | 2 | (13%) | |
Enthesitis related arthritis | 2 | (18%) | 1 | (7%) | |
Psoriatic arthritis | 1 | (9%) | |||
Disease onset age (years) | 6.4 | ± 2.9 | 3.8 | ± 1.9 | 0.012 |
Disease duration at final follow-up (years) | 27.4 | ± 2.3 | 30.1 | ± 2.9 | 0.017 |
Mean age at final follow-up (years) | 33.7 | ± 2.6 | 33.9 | ± 3.0 | 0.72 |
Disease variables at final follow-up: | |||||
Number of active joints (range 0-69) | 1.0 | ± 1.4 | 10.4 | ± 15.0 | 0.033 |
Number of joints with limited range of motion (range 0-69) | 3.2 | ± 4.7 | 24.9 | ± 23.6 | 0.009 |
Physician's global assessment (0-100 mm VAS) | 9.4 | ± 19.1 | 24.9 | ± 30.0 | 0.064 |
Patient's global assessment (0-100 mm VAS) | 4.8 | ± 9.6 | 31.6 | ± 17.4 | 0.001 |
Physical function (HAQ disability index, range 0-3) | 0.5 | ± 0.7 | 0.6 | ± 0.6 | 0.23 |